Table 1 Cochrane review data used as the basis for this analysis
| Â | Donepezil | Rivastigmine | Galantamine | |||
|---|---|---|---|---|---|---|
Daily dose | 5 mg | 10 mg | 1–4 mg | 6–12 mg | 16 mg | 24 mg |
Efficacy* | -1.86 | -2.90 | -0.84 | -2.09 | -3.10 | -3.29 |
   95% CI | -2.60, -1.11 | -3.65,-2.16 | -1.48, -0.19 | -2.65, -1.54 | -4.13, -2.07 | -3.92, -2.65 |
Beta†| -0.071 | -0.106 | -0.036 | -0.091 | -0.105 | -0.124 |
   95% CI | -0.099, -0.042 | -0.133, -0.079 | -0.067, -0.008 | -0.115, -0.067 | -0.14 -0.070 | -0.147, -0.100 |
Withdrawal‡ | 1.02 | 1.36 | 1.01 | 1.95 | 1.34 | 1.51 |
   95% CI | 0.78, 1.33 | 1.10,1.70 | 0.80, 1.27 | 1.65, 2.32 | 0.95, 1.89 | 1.23, 1.87 |